Author:
Russell Dana L.,Uslan Daniel Z.,Rubin Zachary A.,Grogan Tristan R.,Martin Elise M.
Abstract
From 2000 to 2009, rates of multidrug-resistantAcinetobacter baumaniiincreased 10-fold to 0.2 per 1,000 patient days. From 2010 to 2015, however, rates markedly declined and have stayed below 0.05 per 1,000 patient days. Herein, we present a 15-year trend analysis and discuss interventions that may have led to the decline.Infect Control Hosp Epidemiol2018;39:608–611
Publisher
Cambridge University Press (CUP)
Subject
Infectious Diseases,Microbiology (medical),Epidemiology
Reference10 articles.
1. MDRO and C. difficile infection module. Centers for Disease Control and Prevention National Health Safety Network website. https://www.cdc.gov/nhsn/pdfs/pscmanual/12pscmdro_cdadcurrent.pdf. Published January 2017. Accessed November 2017.
2. Antibiotic resistant threats in the United States. Centers for Disease Control and Prevention website. https://www.cdc.gov/drugresistance/threat-report-2013/index.html. Published 2013. Accessed November 2017.
3. Controlling endemic multidrug-resistant <i>Acinetobacter baumannii</i> in Intensive Care Units using antimicrobial stewardship and infection control
4. Successful control of carbapenem-resistant Acinetobacter baumannii in a Korean university hospital: A 6-year perspective
5. Survival of A. baumanii on dry surfaces;Wendt;J Clin Microbiol,1998
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献